Among the five FDA-approved neurotoxins in the US, Daxxify and Dysport represent opposite ends of the most clinically relevant spectrum for male patients: duration and onset. Daxxify, from Revance Therapeutics, is the newest and most differentiated — using a proprietary peptide carrier (RTP004) to claim a 6+ month duration, roughly double the standard. Dysport, from Galderma, is the longest-established alternative to Botox with specific advantages in fast onset and diffusion pattern that make it the preference for certain treatment areas and patient profiles. Understanding the differences helps men and their providers make an evidence-informed choice.
Daxxify: The Extended Duration Claim
Daxxify (daxibotulinumtoxinA-lanm) received FDA approval in 2022 for glabellar lines — the first new botulinum toxin in the US since Jeuveau in 2019. Its clinical differentiator is the RAMPS (Resveratrol-based Absorption and Metabolic Persistence System) peptide carrier technology: the RTP004 peptide helps anchor the toxin at the neuromuscular junction, extending its persistence. Phase 3 trial data showed median duration of approximately 6.1 months at the clinical approval dose — compared to 3-4 months for Botox and Dysport. In real-world clinical practice, the 6-month claim has held for many patients, though some report 4-5 months. For men who want to reduce appointment frequency from 3-4 times per year to 2 times per year, Daxxify's extended duration is a genuine lifestyle advantage.
Dysport: The Fast-Onset, High-Diffusion Alternative
Ready to find a provider near you?
Search by Zip Code →Dysport (abobotulinumtoxinA), from Galderma, has been FDA-approved since 2009 and has decades of international use before that. Its clinical profile is well-characterized: onset typically at 2-3 days (compared to Botox's 3-5 days and Daxxify's reported 3-5 days) and a slightly higher diffusion rate than Botox due to lower-molecular-weight toxin complexes. The higher diffusion means Dysport spreads slightly more broadly from the injection site — an advantage for large, flat areas like the forehead where even coverage is desired, but a potential disadvantage near areas requiring precision (like brow lifting or under-eye work where spread to neighboring muscles is undesirable). Duration is comparable to Botox at 3-4 months.
Direct comparison of Daxxify vs Dysport across key clinical parameters:
- •Duration: Daxxify — 5-7 months in clinical use; Dysport — 3-4 months
- •Onset: Daxxify — 3-5 days; Dysport — 2-3 days (fastest of major neurotoxins)
- •Diffusion pattern: Daxxify — localized (similar to Botox); Dysport — slightly broader spread
- •Unit ratio: Daxxify — doses are fixed (40 units for standard glabellar, not per-area adjustable in the same way); Dysport — typically dosed at 2.5:1 ratio vs Botox
- •FDA approval breadth: Both primarily approved for glabellar lines; off-label use for other areas is standard practice
- •Cost: Daxxify — typically $500-900 per session at current market rates; Dysport — $350-600 per session, comparable to Botox
- •Availability: Dysport — widely available at most aesthetic practices; Daxxify — available at certified Revance practices, not universal coverage yet
Who benefits most from Daxxify: men who have frequent scheduling constraints (travel-heavy professionals, men who keep forgetting to rebook, men who find 3-4x/year frequency a barrier), men with metabolically fast Botox wear-off (who currently experience only 2-2.5 month duration from standard neurotoxins), and men who want to consolidate their annual aesthetic maintenance into fewer higher-value sessions.
Who Benefits Most From Each Option
Ready to find a provider near you?
Search by Zip Code →Dysport advantages for specific male patients: forehead-dominant treatment where broad, even coverage is desired; men who want the fastest possible onset (pre-event timing where 2 vs 4 days matters); men whose providers have extensive Dysport experience; men with Botox resistance who want a different protein complex. Daxxify advantages: men who want to minimize treatment frequency to 2x/year; men willing to pay a premium per session for the convenience of longer duration; men who have found standard neurotoxins lasting only 2.5-3 months and want longer persistence. Neither is superior for all patients — the right choice depends on your specific priorities and how your individual biology responds.
The Cost-Per-Month Analysis
The cleanest way to compare cost between Daxxify and Dysport is cost-per-month of coverage. Dysport treating forehead + frown + crow's feet: approximately $450-600 per session × 3-4 sessions/year = $1,350-2,400 per year, or $112-200 per month. Daxxify treating the same three areas: approximately $600-900 per session × 2 sessions/year = $1,200-1,800 per year, or $100-150 per month. At current market rates, Daxxify's higher per-session cost is partially offset by fewer sessions — making the annual cost comparison closer than the sticker shock of individual sessions suggests. For men to whom this math matters, getting actual quotes from your specific provider and calculating the annual total is more useful than comparing per-unit rates. Find providers offering both options at /find-botox-near-me.